Temat: "anti-VEGF drugs" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Faricimab: an investigational agent targeting the Tie-2/Angiopoietin pathway and VEGF-A for the treatment of retinal diseases.
Autorzy :: Nicolò M; Ospedale Policlinico San Martino IRCCS , Genoa, Italy.; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa , Italy.; Fondazione per la Macula onlus , Genoa, Italy.
Ferro Desideri L; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa , Italy.
Vagge A; Ospedale Policlinico San Martino IRCCS , Genoa, Italy.; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa , Italy.
Traverso CE; Ospedale Policlinico San Martino IRCCS , Genoa, Italy.; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa , Italy.; Pokaż więcej
Źródło :: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2021 Jan 20. Date of Electronic Publication: 2021 Jan 20.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy.
Autorzy :: Iacono P; IRCCS-Fondazione Bietti, Via Livenza 3, 00198 Rome, Italy.
Da Pozzo S; TSRetina, 34121 Trieste, Italy.
Varano M; IRCCS-Fondazione Bietti, Via Livenza 3, 00198 Rome, Italy.
Parravano M; IRCCS-Fondazione Bietti, Via Livenza 3, 00198 Rome, Italy.; Pokaż więcej
Źródło :: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2020 Oct 29; Vol. 13 (11). Date of Electronic Publication: 2020 Oct 29.
Typ publikacji :: Journal Article; Review
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Abicipar pegol: an investigational anti-VEGF agent for the treatment of wet age-related macular degeneration.
Autorzy :: Ferro Desideri L; IRCCS Ospedale Policlinico San Martino, University Eye Clinic of Genoa , Genoa, Italy.
Traverso CE; IRCCS Ospedale Policlinico San Martino, University Eye Clinic of Genoa , Genoa, Italy.; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (Dinogmi), University of Genoa , Genoa, Italy.
Nicolò M; IRCCS Ospedale Policlinico San Martino, University Eye Clinic of Genoa , Genoa, Italy.; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (Dinogmi), University of Genoa , Genoa, Italy.; Macula Onlus Foundation , Genoa, Italy.; Pokaż więcej
Źródło :: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2020 Jul; Vol. 29 (7), pp. 651-658. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Application of Artificial Intelligence in Targeting Retinal Diseases.
Autorzy :: Sorrentino FS; Department of Surgical Sciences, Maggiore Hospital, Azienda USL Bologna, Bologna, Italy.
Jurman G; Unit of Predictive Models for Biomedicine and Environment - MPBA, Fondazione Bruno Kessler, Trento, Italy.
De Nadai K; Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Campa C; Department of Surgical Specialties, Sant'Anna Hospital, Azienda Ospedaliero Universitaria di Ferrara, Ferrara, Italy.
Furlanello C; Unit of Predictive Models for Biomedicine and Environment - MPBA, Fondazione Bruno Kessler, Trento, Italy.
Parmeggiani F; Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.; Pokaż więcej
Źródło :: Current drug targets [Curr Drug Targets] 2020; Vol. 21 (12), pp. 1208-1215.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration.
Autorzy :: Koike N; Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan.
Otsuji T; Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan.
Tsumura A; Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan.
Miki K; Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan.
Sakai Y; Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan.
Nishimura T; Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan.
Takahashi K; Department of Ophthalmology, Kansai Medical University, Osaka, Japan.; Pokaż więcej
Źródło :: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2019 Jul 15; Vol. 13, pp. 1247-1251. Date of Electronic Publication: 2019 Jul 15 (Print Publication: 2019).
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 6 6.

Tytuł :: Acute blood pressure elevation associated with biological therapies for cancer: a focus on VEGF signaling pathway inhibitors.
Autorzy :: Pucci G; a Department of Medicine , University of Perugia , Perugia , Italy.; b Unit of Internal Medicine , Terni University Hospital , Terni , Italy.
Milan A; c Department of Medical Sciences - Hypertension Center , University of Torino - AOU Città della Salute e della Scienza di Torino , Torino , Italy.
Paini A; d Department of Clinical and Experimental Sciences , University of Brescia , Brescia , Italy.
Salvetti M; d Department of Clinical and Experimental Sciences , University of Brescia , Brescia , Italy.
Cerasari A; a Department of Medicine , University of Perugia , Perugia , Italy.; b Unit of Internal Medicine , Terni University Hospital , Terni , Italy.
Vaudo G; a Department of Medicine , University of Perugia , Perugia , Italy.; b Unit of Internal Medicine , Terni University Hospital , Terni , Italy.; Pokaż więcej
Źródło :: Expert opinion on biological therapy [Expert Opin Biol Ther] 2019 May; Vol. 19 (5), pp. 433-442. Date of Electronic Publication: 2019 Apr 08.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antibodies, Monoclonal/*therapeutic use
Neoplasms/*drug therapy
Vascular Endothelial Growth Factor A/*metabolism
Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/pharmacology ; Blood Pressure ; Humans ; Hypertension/etiology ; Hypertensive Encephalopathy/etiology ; Neoplasms/complications ; Neoplasms/pathology ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Signal Transduction/drug effects ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Vascular Endothelial Growth Factor A/immunology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: [Effect of intravitreal injections of ranibizumab and aflibercept on the retinal nerve fiber layer in patients with concomitant neovascular age-related macular degeneration and glaucoma].
Autorzy :: Rud'ko AS; Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021.
Budzinskaya MV; Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021.
Andreeva IV; Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021.
Karpilova MA; Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021.
Smirnova TV; Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021.; Pokaż więcej
Transliterated Title :: Vliianie intravitreal'nykh in''ektsiĭ ranibizumaba i aflibertsepta na sloĭ nervnykh volokon setchatki pri sochetanii neovaskuliarnoĭ vozrastnoĭ makuliarnoĭ degeneratsii i glaukomy.
Źródło :: Vestnik oftalmologii [Vestn Oftalmol] 2019; Vol. 135 (5. Vyp. 2), pp. 177-183.
Typ publikacji :: Journal Article
MeSH Terms :: Glaucoma*/drug therapy
Macular Degeneration*
Ranibizumab/*therapeutic use
Receptors, Vascular Endothelial Growth Factor/*therapeutic use
Recombinant Fusion Proteins/*therapeutic use
Angiogenesis Inhibitors ; Follow-Up Studies ; Humans ; Intravitreal Injections ; Nerve Fibers ; Retrospective Studies ; Tomography, Optical Coherence ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: In vivo antivascular endothelial growth factor treatment induces corneal endothelium apoptosis in rabbits through changes in p75NTR-proNGF pathway.
Autorzy :: Gharbiya M; Department of Sense Organs, University of Rome Sapienza, Rome, Italy.
Bruscolini A; Department of Sense Organs, University of Rome Sapienza, Rome, Italy.
Sacchetti M; Department of Sense Organs, University of Rome Sapienza, Rome, Italy.
Rosso P; National Research Council - Department of Biomedical Sciences, Institute of Cell Biology and Neurobiology (IBCN-CNR), Rome, Italy.
Carito V; National Research Council - Department of Biomedical Sciences, Institute of Cell Biology and Neurobiology (IBCN-CNR), Rome, Italy.
Segatto M; Department of Sense Organs, University of Rome Sapienza, Rome, Italy.
Fico E; National Research Council - Department of Biomedical Sciences, Institute of Cell Biology and Neurobiology (IBCN-CNR), Rome, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Tirassa P; National Research Council - Department of Biomedical Sciences, Institute of Cell Biology and Neurobiology (IBCN-CNR), Rome, Italy.
Lambiase A; Department of Sense Organs, University of Rome Sapienza, Rome, Italy.; Pokaż więcej
Źródło :: Journal of cellular physiology [J Cell Physiol] 2018 Nov; Vol. 233 (11), pp. 8874-8883. Date of Electronic Publication: 2018 Jun 01.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Glaucoma, Neovascular/*drug therapy
Nerve Growth Factor/*genetics
Receptors, Vascular Endothelial Growth Factor/*administration & dosage
Recombinant Fusion Proteins/*administration & dosage
Vascular Endothelial Growth Factor A/*antagonists & inhibitors
Angiogenesis Inhibitors/administration & dosage ; Animals ; Anterior Chamber/drug effects ; Anterior Chamber/pathology ; Apoptosis/genetics ; Cell Survival/drug effects ; Disease Models, Animal ; Endothelial Cells/drug effects ; Endothelium, Corneal/drug effects ; Endothelium, Corneal/pathology ; Gene Expression Regulation/drug effects ; Glaucoma, Neovascular/genetics ; Glaucoma, Neovascular/pathology ; Humans ; Intravitreal Injections ; Rabbits ; Ranibizumab/administration & dosage ; Receptor, Nerve Growth Factor/genetics ; Vascular Endothelial Growth Factor A/genetics ; rhoA GTP-Binding Protein/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Evaluation of vitreoretinal interface changes in patients receiving intravitreal anti-VEGF therapy.
Autorzy :: Kinra V; Regional Institute of Ophthalmology, Pt. Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.
Singh S; Regional Institute of Ophthalmology, Pt. Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.
Khanduja S; Regional Institute of Ophthalmology, Pt. Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. .
Nada M; Regional Institute of Ophthalmology, Pt. Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.; Pokaż więcej
Źródło :: International ophthalmology [Int Ophthalmol] 2018 Apr; Vol. 38 (2), pp. 549-556. Date of Electronic Publication: 2017 Mar 15.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Angiogenesis Inhibitors/*administration & dosage
Bevacizumab/*administration & dosage
Macula Lutea/*pathology
Macular Edema/*drug therapy
Macular Edema/*pathology
Vitreous Body/*pathology
Adult ; Aged ; Female ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Prospective Studies ; Vascular Endothelial Growth Factor A/antagonists & inhibitors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Age-related macular degeneration: using morphological predictors to modify current treatment protocols.
Autorzy :: Ashraf M; Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Souka A; Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Adelman RA; Department of Ophthalmology and Visual Studies, Yale Medical School, European Vitreo-retinal Society (EVRS), New Haven, Connecticut, USA.; Pokaż więcej
Źródło :: Acta ophthalmologica [Acta Ophthalmol] 2018 Mar; Vol. 96 (2), pp. 120-133. Date of Electronic Publication: 2017 Nov 11.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Angiogenesis Inhibitors/*therapeutic use
Vascular Endothelial Growth Factor A/*antagonists & inhibitors
Visual Acuity/*physiology
Wet Macular Degeneration/*diagnosis
Wet Macular Degeneration/*drug therapy
Algorithms ; Clinical Protocols ; Databases, Factual ; Humans ; Patient-Centered Care ; Prognosis ; Tomography, Optical Coherence ; Wet Macular Degeneration/physiopathology
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 11 11.

Tytuł :: Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study.
Autorzy :: Mangoni AA; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Adelaide, Australia.
Kichenadasse G; Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
Rowland A; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
Sorich MJ; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, Australia; Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, Australia.; Pokaż więcej
Źródło :: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2018 Feb 05; Vol. 10, pp. 1758834018755090. Date of Electronic Publication: 2018 Feb 05 (Print Publication: 2018).
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives.
Autorzy :: Nappi A; Medical Oncology, Abdominal Department, National Cancer Institute G. Pascale Foundation, 80131 Napoli, Italy.
Berretta M; Department of Medical Oncology, National Cancer Institute of Aviano, 33081 Aviano (PN), Italy.; Gruppo Oncologico Ricercatori Italiani, Pordenone (PN), Italy.
Romano C; Medical Oncology, Abdominal Department, National Cancer Institute G. Pascale Foundation, 80131 Napoli, Italy.
Tafuto S; Medical Oncology, Abdominal Department, National Cancer Institute G. Pascale Foundation, 80131 Napoli, Italy.
Cassata A; Medical Oncology, Abdominal Department, National Cancer Institute G. Pascale Foundation, 80131 Napoli, Italy.
Casaretti R; Medical Oncology, Abdominal Department, National Cancer Institute G. Pascale Foundation, 80131 Napoli, Italy.
Silvestro L; Medical Oncology, Abdominal Department, National Cancer Institute G. Pascale Foundation, 80131 Napoli, Italy.
Divitiis C; Medical Oncology, Abdominal Department, National Cancer Institute G. Pascale Foundation, 80131 Napoli, Italy.
Alessandrini L; Division of Pathology, National Cancer Institute, Aviano (PN), Italy.
Fiorica F; Division of Radiotherapy, 'Sant'Anna Hospital' Ferrara, Italy.
Ottaiano A; Medical Oncology, Abdominal Department, National Cancer Institute G. Pascale Foundation, 80131 Napoli, Italy.
Nasti G; Medical Oncology, Abdominal Department, National Cancer Institute G. Pascale Foundation, 80131 Napoli, Italy.; Pokaż więcej
Źródło :: Current cancer drug targets [Curr Cancer Drug Targets] 2018; Vol. 18 (5), pp. 421-429.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Molecular Targeted Therapy*
Antineoplastic Agents/*therapeutic use
Colorectal Neoplasms/*drug therapy
Colorectal Neoplasms/*metabolism
Neoplasm Proteins/*antagonists & inhibitors
Colorectal Neoplasms/secondary ; Humans ; Precision Medicine ; Prognosis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Real-Life Experience with Aflibercept and Ranibizumab in the Treatment of Newly Diagnosed Neovascular Age-Related Macular Degeneration over 24 Months.
Autorzy :: Garweg JG; 1 Swiss Eye Institute , Rotkreuz, and Berner Augenklinik am Lindenhofspital, Bern, Switzerland .; 2 University of Bern , Bern, Switzerland .
Gerhardt C; 1 Swiss Eye Institute , Rotkreuz, and Berner Augenklinik am Lindenhofspital, Bern, Switzerland .; 2 University of Bern , Bern, Switzerland .
Kodjikian L; 3 Department of Ophthalmology, Croix-Rousse University Hospital, University Claude Bernard of Lyon 1 , Lyon Cedex, France .
Pfister IB; 1 Swiss Eye Institute , Rotkreuz, and Berner Augenklinik am Lindenhofspital, Bern, Switzerland .; 2 University of Bern , Bern, Switzerland .; Pokaż więcej
Źródło :: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2017 Sep; Vol. 33 (7), pp. 567-572. Date of Electronic Publication: 2017 May 30.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Angiogenesis Inhibitors/*therapeutic use
Ranibizumab/*therapeutic use
Receptors, Vascular Endothelial Growth Factor/*therapeutic use
Recombinant Fusion Proteins/*therapeutic use
Wet Macular Degeneration/*drug therapy
Aged ; Aged, 80 and over ; Female ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Retrospective Studies ; Tomography, Optical Coherence ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Visual Acuity ; Wet Macular Degeneration/diagnosis ; Wet Macular Degeneration/physiopathology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: The Results of the Use of Ahmed Valve in Refractory Glaucoma Surgery.
Autorzy :: Bikbov MM; Chief, Department of Management, Ufa Eye Research Institute Bashkortostan, Russian Federation, Russia.
Khusnitdinov II; Head, Department of Microsurgery II, Ufa Eye Research Institute Bashkortostan, Russian Federation, Russia.; Pokaż więcej
Źródło :: Journal of current glaucoma practice [J Curr Glaucoma Pract] 2015 Sep-Dec; Vol. 9 (3), pp. 86-91. Date of Electronic Publication: 2016 Feb 02.
Typ publikacji :: Journal Article; Review
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Arterial hypertension and cancer.
Autorzy :: Milan A; Department of Medical Sciences, Hypertension Unit, University of Torino, Torino, Italy.
Puglisi E
Ferrari L
Bruno G
Losano I
Veglio F; Pokaż więcej
Źródło :: International journal of cancer [Int J Cancer] 2014 May 15; Vol. 134 (10), pp. 2269-77. Date of Electronic Publication: 2013 Jul 31.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antihypertensive Agents/*therapeutic use
Antineoplastic Agents/*therapeutic use
Hypertension/*drug therapy
Neoplasms/*drug therapy
Antihypertensive Agents/adverse effects ; Antineoplastic Agents/adverse effects ; Humans ; Hypertension/chemically induced ; Neoplasms/chemically induced ; Risk Assessment ; Risk Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Current concepts in intravitreal drug therapy for diabetic retinopathy.
Autorzy :: Pai A; Ophthalmology Section, Surgery Department, Hamad Medical Corporation, Doha, Qatar.
El Shafei MM
Mohammed OA
Al Hashimi M; Pokaż więcej
Źródło :: Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society [Saudi J Ophthalmol] 2010 Oct; Vol. 24 (4), pp. 143-9. Date of Electronic Publication: 2010 Jun 30.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""anti-VEGF drugs"" wg kryterium: Temat

Aktywne filtry:

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język